Clinicopathological and Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach

Table 1

Prognostic factors related to prognosis by the Kaplan-Meier method.

Clinicopathological factors	Total number	Mean time (month)				𝑃 values
		Estimate	Std. error	95% CI
				Lower	Upper
Gender
Female	10	20.700	6.002	8.896	32.504	0.384
Male	21	12.000	2.963	6.192	17.808
Elevation of serum AFP
Yes	27	15.704	3.201	9.429	21.978	0.467
No	4	8.750	2.926	3.015	14.485
Location of cancer
Eso-cardia	10	16.800	5.083	6.837	26.763	0.975
Body	12	12.417	4.485	3.627	21.207
Antrum	9	15.778	5.734	4.538	27.017
pTNM stages
I	7	36.714	5.838	25.272	48.157	0.000
II	6	20.333	3.853	12.782	27.885
III	10	5.800	0.867	4.101	7.499
IV	8	2.750	0.250	2.260	3.240
AFP IHC
Yes	28	14.679	2.902	8.991	20.366	0.037
No	3	37.000	13.503	0.000	42.466
Hep Par 1 IHC
Yes	8	8.625	4.931	0.000	18.291	0.105
No	23	16.957	3.354	10.383	23.530
CEA IHC
Yes	19	8.737	2.867	3.117	14.357	0.008
No	12	24.417	4.642	15.317	33.516
CK20 IHC
Yes	11	3.444	0.556	2.356	4.533	0.000
No	20	19.455	3.545	12.507	26.402
CK7 IHC
Yes	11	3.333	0.715	1.932	4.735	0.000
No	20	17.560	3.284	11.124	23.996
AE1/AE3 IHC
Yes	24	13.571	4.613	4.530	22.613	0.786
No	7	15.167	3.447	8.411	21.922